The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib study of cetuximab + BYL719 + IMRT in stage III-IVB head and neck squamous cell carcinoma (HNSCC).
 
Lara Dunn
Research Funding - Regeneron
 
Nadeem Riaz
Honoraria - MedImmune
Research Funding - Bristol-Myers Squibb
 
Shrujal S. Baxi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca
 
Sean Matthew McBride
No Relationships to Disclose
 
Eric Jeffrey Sherman
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Loxo
Research Funding - Eisai; Roche
 
Loren Michel
No Relationships to Disclose
 
Sofia Haque
No Relationships to Disclose
 
Nora Katabi
No Relationships to Disclose
 
Richard J. Wong
No Relationships to Disclose
 
Han Xiao
No Relationships to Disclose
 
Nancy Y. Lee
Consulting or Advisory Role - Lilly; Merck; Pfizer; Vertex
Research Funding - Pfizer
 
Matthew G. Fury
Employment - Regeneron; Regeneron (I)
Stock and Other Ownership Interests - Regeneron; Regeneron (I)
Consulting or Advisory Role - Egenix
Research Funding - AstraZeneca/MedImmune; Novartis; Regeneron
Patents, Royalties, Other Intellectual Property - Regeneron (I)
 
Alan Loh Ho
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Genzyme; Kura Oncology; Merck; Novartis; Novartis; oncology consortium; Sun Pharma; Sun Pharma
Speakers' Bureau - Medscape; Omniprex America
Research Funding - AstraZeneca; AstraZeneca; Bayer; Eisai; Genentech/Roche; Kolltan Pharmaceuticals; Kura Oncology; Lilly
Travel, Accommodations, Expenses - Janssen Oncology; Kura Oncology; Merck
 
David G. Pfister
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - AstraZeneca; Boehringer Ingelheim; Exelixis; MedImmune; Merck; Novartis